InvestorsHub Logo
icon url

McMagyar

12/20/22 10:01 AM

#393555 RE: Pazzo1212 #393554

So just to be clear..
We are the mushrooms
You pay TGD a lot of money
to try and get this right..

We are longs and we are along for the ride
icon url

Kb1123

12/20/22 10:01 AM

#393556 RE: Pazzo1212 #393554

Agreed
icon url

Investor2014

12/20/22 10:01 AM

#393557 RE: Pazzo1212 #393554

You!

“Who is calling IR to inquire about the other 6 catalysts “Expected” to happen by the end of 2022??”
icon url

JWC3

12/20/22 10:09 AM

#393559 RE: Pazzo1212 #393554

In due time, the data will be given out the shareholders and public to be educated. However, it is the historically significant TLR of ANAVEX P2a/3 AD trial with all endpoints met that now guides the ANAVEX ship, and actions going forward. Developing A 2-73 for AD is the most financially impactful action that ANAVEX can take! It is number one. Everything else is a distant second.
icon url

Hoskuld

12/20/22 10:11 AM

#393560 RE: Pazzo1212 #393554

No Pazzo, that is not the way it works. The company reads the safe harbor statement and then puts out its more-or-less ideal scenario. Only extremely naive people believe that no additional time or money will be needed. Most of us understand that it takes about twice as much time and money as initial projected and that underestimation is a fact of life as certain as death and taxes.

The company has now had two extremely successful P3 trials completed for two different indications: Rett and AD. This is extraordinary and despite the stock price not yet reacting, the CEO and everyone in the company is entitled to take a bow and receive a bonus.